Actively Recruiting
Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder
Led by Sultan 1. Murat State Hospital · Updated on 2026-01-12
100
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, the investigators aimed to evaluate the impact of having a child diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) on parental disease burden in mothers diagnosed with Fibromyalgia Syndrome (FMS). The study will include 50 mothers with FMS who have a child diagnosed with ADHD and 50 mothers with FMS who have children without any psychiatric disorders. Among mothers of children followed with a diagnosis of ADHD at the Child and Adolescent Psychiatry Outpatient Clinic of Edirne Sultan 1st Murat State Hospital, the presence of widespread body pain will be assessed. Mothers reporting widespread body pain will be referred to the Pain Management Outpatient Clinic of the same hospital for further evaluation for FMS. Mothers diagnosed with FMS will be included in the study group. The comparison group will consist of mothers with FMS who have children without any psychiatric disorders. These participants will be selected from patients diagnosed with FMS who present to the Pain Management Outpatient Clinic of Edirne Sultan 1st Murat State Hospital.
CONDITIONS
Official Title
Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged between 18 and 50 years
- Having one or more children aged 6 to 17 years diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) according to DSM-5 criteria, or having children without any psychiatric disorders
- Diagnosed with Fibromyalgia Syndrome according to the 2016 American College of Rheumatology criteria
- Being literate
You will not qualify if you...
- Receiving regular pharmacological treatment for Fibromyalgia Syndrome
- Having an active psychiatric disorder or using psychiatric medication
- History of infectious disease, chronic inflammatory disease, or malignancy
- Being pregnant or breastfeeding
- Having a central or peripheral nervous system disorder (e.g., cerebrovascular disease, multiple sclerosis)
- Being uncooperative during clinical evaluation
- Having comorbid conditions affecting quality of life such as congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes mellitus, or peripheral vascular disease
- Having a diagnosis of hypothyroidism or hyperthyroidism
- Having substance use disorder or alcohol use disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sultan 1. Murat State Hospital
Edirne, Turkey (Türkiye), 22030
Actively Recruiting
Research Team
A
Alper Mengi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here